SCHEMBL2837951

SCHEMBL2837951

CCOC(=O)NC(Cc1ccco1)C(=O)OCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.50
CTSK P43235 1/20 0.50
ALDH1A1 P00352 8/20 0.44
POLB P06746 4/20 0.44
MAPT P10636 3/20 0.44
TSHR P16473 1/20 0.43
APEX1 P27695 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
GAA P10253 1/20 0.42
KDM4E B2RXH2 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
HSD17B10 Q99714 2/20 0.40
TP53 P04637 1/20 0.40
HPGD P15428 1/20 0.40
LMNA P02545 1/20 0.40
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3573493 0.90 CTSS (0.52) CTSSCTSKALDH1A1POLBMAPT
SCHEMBL2668227 0.86 ALDH1A1 (0.46) CTSSCTSKALDH1A1POLBMAPT
SCHEMBL4114851 0.85 CTSS (0.42) CTSSCTSKALDH1A1POLBMAPT
SCHEMBL7892545 0.82 ALDH1A1 (0.43) CTSSCTSKALDH1A1POLBTSHR
SCHEMBL4109092 0.80 CTSS (0.56) CTSSCTSKALDH1A1POLBMAPT
SCHEMBL1064459 0.78 CTSK (0.48) CTSSCTSKPOLBMAPTTSHR
SCHEMBL2668375 0.77 TSHR (0.39) CTSSCTSKALDH1A1POLBMAPT
SCHEMBL6778635 0.77 ALDH1A1 (0.49) ALDH1A1POLBMAPTTSHRL3MBTL1
SCHEMBL10964365 0.77 MMP8 (0.56) CTSSCTSKALDH1A1POLBGAA
Hydrochloric Acid SCHEMBL6777275 0.75 ALDH1A1 (0.47) ALDH1A1POLBMAPTTSHRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 CTSS 1124/4885CTSK 1678/4885ALDH1A1 66/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.